1. Analyst View
2. Research Overview
3. Industry Overview
3.1 Biotechnology Industry Worldwide
3.2 US Biotech Industry
4. Industry Performance
4.1 Bio Medical
4.1.1 Current Biomedical Business Models
4.1.1.1 Fully Integrated Companies (FICOs: FIPCOs, FIBCOs, FICOPs)
4.1.1.2 Non Research Development Only (NRDOs)
4.1.1.3 Platform Model
4.1.1.4 Mixed Models
4.1.1.5 Medical Device Model
4.1.2 Stages of Growing Biomedical Firm
4.2 Agriculture Biotechnology
4.2.1 Production and Economic Impacts
4.2.2 Adoption of Biotechnology Derived Crops
4.2.3 Biotechnology and Biofuels
4.3 Clinical Trials
4.4 Mergers and Acquisitions
4.5 Strategic Alliances
4.6 Biotech Funding (Public, Private & Venture Capital)
4.7 Biotech Research Parks
4.7.1 Cummings Research Park, Huntsville
4.7.2 ASU (Arizona State University) Research Park
4.7.3 Texas Research Park
4.7.4 Delaware Technology Park
4.7.5 Massachusetts Biotechnology Research Park
4.7.6 UK (University of Kentucky) Coldstream Research Campus
4.7.7 InterTech Science Park
4.7.8 Chicago Technology Park
5. US Bio Cluster
5.1 New York
5.2 North-West Pennsylvania
5.3 Massachusetts
5.4 California
5.5 Washington
6. Industry Analysis
6.1 Key Drivers
6.1.1 Increasing Financing Option
6.1.2 Strong and Stable Biotech Sector
6.1.3 Environmental Drivers
6.1.4 Sociological Drivers
6.1.5 Patent System
6.1.6 Federal Funding
6.1.7 FDA Biopharmaceuticals Approvals
6.1.8 Technology
6.2 Opportunities
6.2.1 Opportunity for Developers of Innovative Health Solutions
6.2.2 Biofertilizers/BioPesticides
6.2.3 Agricultural Biotechnology
6.2.4 Biofuel
6.3 Challenges
6.3.1 Consumer Preferences & Market Uncertainty
6.3.2 Cost Pressures
6.3.3 Competition from Developing Countries like India & China
6.3.4 Public Acceptance
6.4 Future Outlook, 2010
7. Key Players and Company Profiles
7.1 Chiron Corporation
7.2 Amgen Inc.
7.3 Biogen Idec, Inc.
7.4 Applied Biosystems
7.5 Genentech
7.6 Baxter International Inc.
8. Annexure I: Government Initiatives and Regulations
8.1 Food and Drug Administration (FDA)
8.1.1 Food
8.1.2 Regulation of Drugs and Biologic Products
8.2 United States Department of Agriculture (USDA)
8.3 United States Environmental Protection Agency (USEPA)
